AB Corporate Return on Average Equity from 2010 to 2024
| EYEG Etf | USD 34.66 0.31 0.89% |
Check AB Corporate financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EYEG main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . EYEG financial statements analysis is a perfect complement when working with AB Corporate Valuation or Volatility modules.
EYEG |
About AB Corporate Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include AB Corporate income statement, its balance sheet, and the statement of cash flows. AB Corporate investors use historical funamental indicators, such as AB Corporate's Return on Average Equity, to determine how well the company is positioned to perform in the future. Although AB Corporate investors may use each financial statement separately, they are all related. The changes in AB Corporate's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AB Corporate's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AB Corporate Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AB Corporate. Please read more on our technical analysis and fundamental analysis pages.
EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system in the United States. Eyegate Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Waltham, Massachusetts. Eyegate Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Pair Trading with AB Corporate
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AB Corporate position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AB Corporate will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to AB Corporate could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AB Corporate when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AB Corporate - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AB Corporate Bond to buy it.
The correlation of AB Corporate is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AB Corporate moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AB Corporate Bond moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AB Corporate can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of AB Corporate Correlation against competitors. Note that the AB Corporate Bond information on this page should be used as a complementary analysis to other AB Corporate's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
The market value of AB Corporate Bond is measured differently than its book value, which is the value of EYEG that is recorded on the company's balance sheet. Investors also form their own opinion of AB Corporate's value that differs from its market value or its book value, called intrinsic value, which is AB Corporate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AB Corporate's market value can be influenced by many factors that don't directly affect AB Corporate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AB Corporate's value and its price as these two are different measures arrived at by different means. Investors typically determine if AB Corporate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AB Corporate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.